The Biologics Contract Manufacturing Demand Market in 2023 is US$ 17.41 billion, and is expected to reach US$ 39.31 billion by 2031 at a CAGR of 10.72%.
FutureWise Research published a report that analyzes Biologics Contract Manufacturing Demand Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian